| abstract |
The invention relates to a drug for treating a respiratory disease selected from the group including rhinosinusitis, sinusitis, tonsillitis, bronchiolitis, pneumonia and acute respiratory distress syndrome, containing glutaryl histamine or its pharmaceutically acceptable salt in an effective amount. The invention also includes the use of glutaryl histamine or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of respiratory tract disease. This drug allows you to increase the effectiveness of antibiotic therapy in the treatment of respiratory diseases. |